Glycolysis Metabolites and Risk of Atrial Fibrillation and Heart Failure in the PREDIMED Trial

The increased prevalence of atrial fibrillation (AF) and heart failure (HF) highlights the need to better understand the mechanisms underlying these cardiovascular diseases (CVDs). In the present study, we aimed to evaluate the association between glycolysis-related metabolites and the risk of AF an...

Descripción completa

Detalles Bibliográficos
Autores principales: Becerra-Tomás, Nerea, Ruiz-Canela, Miguel, Hernández-Alonso, Pablo, Bulló, Mònica, Li, Jun, Guasch-Ferré, Marta, Toledo, Estefanía, Clish, Clary B., Estruch, Ramon, Ros, Emilio, Fitó, Montserrat, Lee, Chih-Hao, Pierce, Kerry, Arós, Fernando, Serra-Majem, Lluís, Liang, Liming, Razquin, Cristina, Gómez-Gracia, Enrique, Martínez-González, Miguel A., Hu, Frank B., Corella, Dolores, Salas-Salvadó, Jordi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151758/
https://www.ncbi.nlm.nih.gov/pubmed/34064960
http://dx.doi.org/10.3390/metabo11050306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151758/
https://www.ncbi.nlm.nih.gov/pubmed/34064960
http://dx.doi.org/10.3390/metabo11050306

Ejemplares similares